Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Effects of Phosphodiesterase Inhibitors on Contraction Induced by Endothelin-1 of Isolated Human Prostatic Tissue
Urology, 07/02/09
Kedia GT et al. - The results have provide additional evidence that the function of prostatic smooth muscle is under the control of peptidergic and cyclic nucleotide (cyclic guanosine monophosphate, cyclic adenosine monophosphate)-mediated pathways. This might give a rationale for the use of drugs interacting with cyclic guanosine monophosphate or cyclic adenosine monophosphate signaling, such as PDE inhibitors or nitric oxide donors, in the pharmacotherapy of the benign prostatic syndrome.
Related Articles
Platelet Cyclic Guanosine Monophosphate as a Biomarker of Phosphodiesterase Type 5 Inhibitor Efficacy in the Treatment of Erectile Dysfunction: A Randomized Placebo-Controlled Study
European Urology, 11/05/09
Relevance Score: 67%
Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis
Annals of Internal Medicine, 10/23/09
Relevance Score: 67%
Erectile Dysfunction: Treatment With Oral Medications Demonstrates Significant Improvements In Sexual Intercourse And Erectile Function
ScienceDaily, 10/20/09
Relevance Score: 66%
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/30/09
Relevance Score: 65%
Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine
Therapeutic Advances in Urology, 10/08/09
Relevance Score: 65%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort
Modern Pathology, 02/09/10
Genetic alterations and changes in expression of histone demethylases in prostate cancer
The Prostate, 02/08/10
Transforming growth factor beta-1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro
The Prostate, 02/08/10
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Ketorolac is Underutilized After Ureteral Reimplantation Despite Reduced Hospital Cost and Reduced Length of Stay
Urology, 02/09/10
The Effect of Epigenetic Therapy on Congenital Neurogenic Bladders : A Pilot Study
Urology, 02/09/10
Intraoperative administration of dexmedetomidine reduces the analgesic requirements for children undergoing hypospadius surgery
European Journal of Anaesthesiology, 02/09/10
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Biomarkers of Systemic Inflammation and Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial
American Journal of Epidemiology, 02/09/10
Immediate Risk of Suicide and Cardiovascular Death After a Prostate Cancer Diagnosis: Cohort Study in the United States
Journal of the National Cancer Institute, 02/08/10
Immunotherapy for Prostate Cancer: An Emerging Treatment Modality
Urologic Clinics of North America, 02/08/10
Article Search
Sponsor


See Latest Articles


